100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
79560-19-3Sertraline Tetralone Racemate
● In Stock
| Catalogue No.: | VE008994 |
|---|---|
| CAS No.: | 79560-19-3 |
| Mol. Formula: | C16H12Cl2O |
| Mol. Weight: | 291.2 g/mol |
Additional information on CAS 79560-19-3
Parent drug
SertralineIUPAC Name
4-(3,4-Dichlorophenyl)-1-tetralonePharmacopeial Synonyms
N/ASynonyms
4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone; 4-(3,4-dichlorophenyl)tetralin-1-oneSmiles
O=C1CCC(C2=CC=C(Cl)C(Cl)=C2)C3=C1C=CC=C3InChI
InChI=1S/C16H12Cl2O/c17-14-7-5-10(9-15(14)18)11-6-8-16(19)13-4-2-1-3-12(11)13/h1-5,7,9,11H,6,8H2Shipping Condition
Ambient TemperatureDescription
Sertraline Tetralone Racemate (CAS 79560-19-3), also known as 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone or 4-(3,4-dichlorophenyl)tetralin-1-one, is a stereoisomeric impurity encountered in sertraline manufacture. As a tetralone intermediate, it can persist due to incomplete reduction or racemization during synthesis and affects enantiomeric purity, residual solvent profile, and downstream crystallization behavior. Accurate identification and quantification by HPLC, chiral HPLC, LC-MS and NMR are essential for impurity profiling and specification setting in accordance with ICH guidelines. Removal is typically achieved through optimized reaction control, targeted purification by chromatography or recrystallization, and validation of analytical methods to ensure batch consistency.Request a Quote
"*" indicates required fields
Other products related to Sertraline impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
